C

Crucell

Acquired

Leiden, Netherlands · Founded 2000 · $97.0M raised

Headquarters
Leiden
Employees
201–500
Founded
2000
Business Model
B2B
Total Funding
$97.0M
Last Round
$97.0M Venture RoundJan 2001
Rounds
1
Acquired by
Johnson & JohnsonApr 2011

About

Crucell was a global biopharmaceutical company headquartered in Leiden, Netherlands, dedicated to developing vaccines and antibody-based medicines for infectious diseases. Founded in 2000 through a merger of Dutch biotech companies IntroGene and U-BiSys, Crucell pioneered the AdVac and PER.C6 cell-line manufacturing platforms for producing next-generation vaccines including those targeting hepatitis B, malaria, and childhood diseases. The company was acquired by Johnson & Johnson in 2011 and subsequently folded into Janssen Vaccines.

Summary

Crucell is a Biotechnology company based in Leiden, Netherlands, founded in 2000. It has raised $97.0M in total across 1 round, most recently a $97.0M Venture Round round in Jan 2001. Investors include Johnson & Johnson Innovation, Alta Partners and Atlas Venture.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

AcquisitionApr 2011
$2.4B

Sign up to see all 2 rounds

Venture Round through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Crucell on Indexed.vc
<a href="https://indexed.vc/companies/crucell"><img src="https://indexed.vc/api/badge/company/crucell" alt="Crucell on Indexed.vc" width="260" height="76" /></a>